Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-02-06 @ 6:04 AM
Study NCT ID:
NCT01397305
Status:
COMPLETED
Last Update Posted:
2020-09-09
First Post:
2011-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Sponsor:
Isofol Medical AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-25
First Submit QC Date:
None
Study First Post Date:
2011-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-07
Last Update Post Date:
2020-09-09
Last Update Post Date Type:
ACTUAL